Investigation of Runx1 and Cathepsin-L as potential therapeutic targets for myocardial infarction and cardiac ischaemia-reperfusion injury
Myocardial infarction (MI) is a leading cause of death worldwide. The fundamental treatment for MI is reperfusion of the ischaemic myocardium by primary percutaneous intervention (PPCI). Advances in PPCI techniques in recent years has led to an increased survival rate in patients undergoing MI. A la...
| Main Author: | |
|---|---|
| Published: |
University of Glasgow
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.716912 |